Finepoint Capital LP holds a concentrated book of 6 stocks worth $461.0M as of Q2 2026 (disclosed Aug 13, 2026, a ~44-day 13F lag). This quarter they trimmed Rxo Inc. Their largest long position is Qxo Inc at 68% of the equity book. They also disclosed $1.7B in put options (a bearish bet) and $592.1M in call options (bullish), shown separately below and excluded from the equity book.
Top-heavy: concentrated book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
100% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices, no cost basis
Other tracked managers holding the same core names as Finepoint Capital LP
| Manager / fund | Shared names | Their $ in those |
|---|---|---|
| MFN Partners Management, LP | 2 / 6 | $1.2B |
| Orbis Allan Gray Ltd | 2 / 6 | $2.3B |
| FRED ALGER MANAGEMENT, LLC | 2 / 6 | $442.5M |
| Hood River Capital Management LLC | 2 / 6 | $264.1M |
| Neo Ivy Capital Management | 2 / 6 | $4.8M |
| Aureus Asset Management, LLC | 2 / 6 | $7.4M |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 2 / 6 | $45.8M |
| DELTEC ASSET MANAGEMENT LLC | 2 / 6 | $2.5M |
Ranked by the share of each fund's own book sitting in the names it shares with Finepoint Capital LP: only funds sharing at least a tenth of the book qualify. Index giants, bank custody books and market makers are excluded. They hold everything, so their overlap says nothing.
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Qxo Inc COM NEW | $313.0M | 18.11M | 67.9% | ▲+31% Added · +4.3M sh | |
| 2 | Rxo Inc COMMON STOCK | $147.8M | 5.36M | 32.0% | ▼−47% Reduced · −4.7M sh | |
| 3 | Aleanna Inc *W EXP 12/13/202 | $147K | 490.0K | 0.0% | —Held | |
| 4 | Aleanna Inc COM CL A | $80K | 27.7K | 0.0% | —Held | |
| 5 | Moneyhero Limited *W EXP 09/13/202 | $37K | 895.0K | 0.0% | —Held | |
| 6 | Calidi Biotherapeutics Inc COM | $177 | 1.0K | 0.0% | —Held |
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1608126/holdings"
Use Arkolith to show Finepoint Capital LP's latest holdings, largest changes, and filing provenance.
Put / call positions from the 13F — totals include every disclosed option leg
| Type | Underlying | Notional value | Underlying shares |
|---|---|---|---|
| PUT · bearish | SS SPDR S&P 500 ETF TRUST-USSPY | $1.3B | 1.7M |
| CALL · bullish | MICROSOFT CORPMSFT | $592.1M | 1.6M |
| PUT · bearish | INVESCO QQQ TRUST SERIES 1QQQ | $467.4M | 635K |
13F filers disclose option positions at the market value of the underlying the contracts reference, not the premium paid. A put is a bearish bet (it gains if the stock falls); a call is bullish. “Underlying shares” is the share count the contracts control, not a share holding. These legs are excluded from the equity book, weighting, concentration and sector figures above.
As-of date vs the date the SEC received each filing
| Quarter | As of | Filed | Positions | Value | Form |
|---|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | Aug 13, 2026 | 9 | $2.8B | 13F-HR |
| Q1 2026 | Mar 31, 2026 | May 14, 2026 | 9 | $2.0B | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Feb 13, 2026 | 9 | $2.0B | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Nov 13, 2025 | 9 | $1.7B | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Aug 13, 2025 | 10 | $1.4B | 13F-HR |
| Q1 2025 | Mar 31, 2025 | May 14, 2025 | 25 | $1.3B | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Feb 13, 2025 | 26 | $1.6B | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Nov 13, 2024 | 26 | $1.4B | 13F-HR |
| Q2 2024 | Jun 30, 2024 | Aug 13, 2024 | 25 | $352.3M | 13F-HR |
| Q1 2024 | Mar 31, 2024 | May 14, 2024 | 26 | $389.9M | 13F-HR |
| Q4 2023 | Dec 31, 2023 | Feb 13, 2024 | 27 | $317.0M | 13F-HR |
| Q3 2023 | Sep 30, 2023 | Nov 13, 2023 | 30 | $200.8M | 13F-HR |
| Q2 2023 | Jun 30, 2023 | Aug 11, 2023 | 37 | $289.1M | 13F-HR |
| Q1 2023 | Mar 31, 2023 | May 12, 2023 | 38 | $261.8M | 13F-HR |
| Q4 2022 | Dec 31, 2022 | Feb 13, 2023 | 44 | $309.3M | 13F-HR |
| Q3 2022 | Sep 30, 2022 | Nov 10, 2022 | 57 | $304.0M | 13F-HR |
| Q2 2022 | Jun 30, 2022 | Aug 12, 2022 | 60 | $289.2M | 13F-HR |
| Q1 2022 | Mar 31, 2022 | May 13, 2022 | 63 | $300.8M | 13F-HR |
| Q4 2021 | Dec 31, 2021 | Feb 11, 2022 | 71 | $390.1M | 13F-HR |
| Q3 2021 | Sep 30, 2021 | Nov 12, 2021 | 74 | $585.7M | 13F-HR |
| Q2 2021 | Jun 30, 2021 | Aug 13, 2021 | 43 | $533.4M | 13F-HR |
| Q1 2021 | Mar 31, 2021 | May 14, 2021 | 1 | $0 | 13F-HR |
| Q4 2020 | Dec 31, 2020 | Feb 12, 2021 | 1 | $2.5M | 13F-HR |
| Q3 2020 | Sep 30, 2020 | Nov 13, 2020 | 1 | $83.1M | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly, filed up to 45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. Price-derived performance is withheld until the price-source policy and freshness gate are green.